December 21, 2016
Premaitha buys Taiwanian bioinformatic company
Premaitha has announced the conditional acquisition of the entire issued share capital of Yourgene.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
December 20, 2016
Allergan eats LifeCell for $2,9 billion
Allergan has acquired the regenerative medicine company LifeCell for $2.9 billion in cash.
December 20, 2016
BMS gets exclusive rights to study PsiOxus’s cancer drug
Bristol-Myers Squibb and PsiOxus Therapeutics have entered into an agreement granting Bristol-Myers Squibb exclusive worldwide rights to NG-348, a pre-clinical…
December 20, 2016
Japan to step up drug price reviews in bid to curbhealthcare costs
Japan said on Tuesday it will step up the pace and expand the scope of drug price reviews, one of the most aggressive measures it is taking to rein in ballooning healthcare costs for a rapidly ageing nation.
December 20, 2016
Pharnext enrolls patients for Charcot-Marie-Tooth disease study in Europe, US, and Canada.
A French biopharmaceutical company Pharnext set to produce treatments to tackle neuropathy diseases, has completed patient enrollment for its international…
December 20, 2016
Novartis buys private US-based pharma company, exapnds its ophtalmology pipeline
Novarits is expanding its ophthalmology pipeline as it secured the ownership of a US-based private company focused on treating long-sightedness.
December 20, 2016
Not your mother’s Pap smear
Confused about when to get your next Pap test? Anxious because your doctor said you don’t need another Pap for five years? Well, you are not alone.
December 20, 2016
GSKs two-drug HIV treatment regimen could become one tablet
Two phase III studies of two-drug HIV treatment regimen conducted by GSK’s HIV specialist ViiV Healthcare, Pfizer and Shinogi Limited,…
December 20, 2016
Biogen names Michel Vounatsos new CEO
Biogen’s Board of Directors has appointed Michel Vounatsos as Chief Executive Officer and member of the Board of Directors, effective…
December 20, 2016
Silence Therapeutics settles with Quark Pharmaceuticals
Silence Therapeutics and Quark Pharmaceuticals have settled in the arbitration regarding a milestone payment, as Silence is to receive a…